View Older Stories
-
RBC Capital Reiterates Outperform Rating on Intuitive Surgical (ISRG)
-
Intuitive Surgical (ISRG) PT Raised to $620 at Piper Sandler as 'Q4 Margins Shine'
-
Intuitive Surgical (ISRG) PT Raised to $615 at Raymond James
-
Intuitive Surgical (ISRG) PT Lowered to $550 at Evercore ISI
-
Intuitive Surgical (ISRG) PT Raised to $750 at Bernstein SocGen Group
-
After-hours movers: Intel, Spotify, Alcoa, Intuitive Surgical and more
-
Intuitive Surgical (ISRG) Tops Q4 EPS by 27c
-
Intuitive Surgical (ISRG) call put ratio 1.9 calls to 1 put into quarter results
-
Intuitive Surgical (ISRG) call put ratio 1 call to 1.3 puts into quarter results
-
Bernstein on Intuitive Surgical (ISRG): 'Top Pick'
-
UBS Reiterates Neutral Rating on Intuitive Surgical (ISRG)
-
Intuitive reports 19% revenue growth in fourth quarter 2025
-
3 MedTech stocks poised for a rebound after a choppy 2025: analyst
-
Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'
-
Goldman: 'Top Call Buying Opportunities for 2026'
-
Intuitive Surgical (ISRG) PT Raised to $616 at BTIG
-
Citi Adjusts Large Cap Recommended List, Micron (MU) Removed
-
Intuitive receives FDA clearance for da Vinci SP surgical procedures
-
Intuitive Surgical (ISRG) on Watch Amid Circulated Comments
-
Intuitive Surgical (ISRG) PT Raised to $560 at Freedom Capital Markets
-
Intuitive Surgical (ISRG) PT Raised to $600 at UBS
-
Intuitive Surgical (ISRG) October 24 weekly calls active as share price up 14.6%
-
Intuitive Surgical (ISRG) PT Raised to $620 at Truist Securities
-
Intuitive Surgical (ISRG) PT Raised at Piper Sandler After an 'Across-The-Board Strong Q3'
-
Intuitive Surgical (ISRG) PT Raised to $600 at Leerink Partners
-
Intuitive Surgical (ISRG) PT Raised to $589 at BTIG
-
Intuitive Surgical (ISRG) PT Raised to $625 at RBC Capital
-
Intuitive Surgical (ISRG) PT Raised to $540 at Evercore ISI
-
After-hours movers: Netflix, Intuitive Surgical, DraftKings, Texas Instruments
-
Intuitive Surgical (ISRG) Tops Q3 EPS by 41c
-
Intuitive Surgical is due to report on Tuesday. Here's what to watch out for.
-
Bernstein on Intuitive Surgical (ISRG): 'Upside to Q3 on Placements & Procedures'
-
Intuitive receives FDA clearance for AI-enhanced Ion lung biopsy system
-
Bernstein sees 'a strong buying opportunity' in this U.S. medical stock
-
Bernstein on Intuitive Surgical (ISRG): 'We See a Strong Buying Opportunity Here'
-
BofA Adjusts US 1 List
-
Needham: 'we believe that the Section 232 investigation creates a new overhang for the already beleaguered medical device sector'
-
Bernstein sees an 'enhanced buying opportunity' in this medical devices stock
-
Bernstein SocGen Group Reiterates Outperform Rating on Intuitive Surgical (ISRG)
-
Piper Sandler on Intuitive Surgical (ISRG): 'No Change To Our Positive View'
-
This MedTech stock is 'a strong buy under $500': Bernstein
-
Intuitive Surgical (ISRG) PT Raised to $615 at RBC Capital
-
Intuitive Surgical (ISRG) PT Raised at Bernstein; 'As "Broad Launch" Begins, We're Buyers'
-
Erste Group Downgrades Intuitive Surgical (ISRG) to Hold
-
Stifel Reiterates Buy Rating on Intuitive Surgical (ISRG)
-
Raymond James Reiterates Outperform Rating on Intuitive Surgical (ISRG)
-
Intuitive Surgical (ISRG) PT Raised to $571 at BTIG
-
Intuitive Surgical (ISRG) PT Raised to $595 at Piper Sandler
-
Intuitive Surgical (ISRG) PT Raised to $600 at Baird
-
After-hours movers: Texas Instruments, Intuitive Surgical, Enphase Energy, and more

